The decree of the Ministry of Health has been published in the Official Journal with the list of oncological pathologies for which shorter terms apply than those provided for by the law on oncological oblivion of 2023. The general term provides for oncological oblivion 10 years after the end of the treatment. The table identifies the neoplasms for which this term is reduced compared to the limit of 10 years or 5 years if the diagnosis is before the age of 21, from the end of treatment or from the last surgery. The times are also reduced to just one year from the end of treatment. Oncological oblivion allows you to eliminate the obligation to declare the neoplasm from which you have suffered after a set deadline. Until now, the declaration of the state of illness implied, as repeatedly reported by patients’ associations, discrimination and difficulties in accessing mortgages, banking procedures and adoptions. In many European countries there has been a law on oncological oblivion for some time. For stage 1 colorectal cancer of any age, the years from the end of treatment are reduced to one. For stages two and three, for those over 21 years of age the deadline drops to 7 years from the end of the treatments.
For melanoma for those over 21 years of age the deadline changes to 6 years.
For stage 1 and 2 breast cancer at any age the deadline drops to one year; for the cervix, for those over 21 the term drops to 6 years. For cancer of the body of the uterus, at any age, the term drops to 5 years; for the testicle, at any age it drops to 1 year.
Finally, for thyroids under 55 years of age for women and under 45 years of age for men (excluding anaplastic tumors for both sexes) the term drops to one year. For Hodgkin lymphomas for those under 45 years of age the term drops to 5 years. Finally, for acute leukemias (lymphoblastic and myeloid) of any age, the term drops to 5 years.
breaking latest news © Copyright ANSA